The Latest Cardiac and Vascular News
This is the second Fast Track designation issued by the FDA for abelacimab Abelacimab is a dual-acting, once-monthly, fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity CAMBRIDGE, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for […]
– Abbott’s Talisman system seals an opening in the heart known as a “patent foramen ovale” (PFO) to prevent blood clots from passing from the right to the left side of the heart and on to the brain, where they can cause a stroke – The Talisman system builds on […]
REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 […]
Physicians in Europe now have access to Penumbra’s latest stroke technology for mechanical thrombectomy RED® reperfusion catheters are designed with optimized trackability and aspiration efficiency to help navigate the complex anatomy of the brain and deliver powerful aspiration for the removal of blood clots Initial INSIGHT Registry data presented at WFITN […]
BOSTON, Aug. 29, 2022 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced completion of the first eShunt® procedure in the United States. The study, ‘US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus (NPH)’, is being conducted under an investigational device […]
Initial INSIGHT Registry data demonstrated RED® reperfusion catheters were highly effective in removing all clot types with an impressive 68.9% mTICI > 2b-3 overall first pass effect rate COMPLETE study sub-analyses of tandem lesions and late window showed aspiration thrombectomy with Penumbra System® restored blood flow and resulted in improved 90-day […]
Independent Data Presented at the World Federation of Interventional and Therapeutic Neuroradiology 2022 Annual Meeting Highlights the Benefits of Vessel-Matching with Zoom Reperfusion Catheters CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that new data evaluating the utility of the Zoom Stroke Solution were presented at the World Federation of Interventional […]
Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study. DIVE is designed to measure the effectiveness of IRRAflow to treat intraventricular hemorrhage versus standard EVD treatment. The Neurosurgery and Neurology Departments at The Mount Sinai Hospital were recently ranked […]
Canada is the first to benefit from the Vena BDAC™ technology developed right in the patient’s backyard for those requiring mechanical thrombectomy during ischemic stroke treatment. Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) — Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five […]
US Based Pilot Study to enroll patients who develop communicating hydrocephalus following subarachnoid hemorrhage BOSTON, Aug. 9, 2022 /PRNewswire/ — CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption […]
